nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—HTR2C—metabolic syndrome X	0.809	1	CbGaD
Escitalopram—Seasonal allergy—Metformin—metabolic syndrome X	0.00801	0.0583	CcSEcCtD
Escitalopram—Rhinitis seasonal—Metformin—metabolic syndrome X	0.00768	0.0559	CcSEcCtD
Escitalopram—Tonsillitis—Metformin—metabolic syndrome X	0.00664	0.0483	CcSEcCtD
Escitalopram—Citalopram—HTR2C—metabolic syndrome X	0.0063	1	CrCbGaD
Escitalopram—Taste metallic—Metformin—metabolic syndrome X	0.00528	0.0384	CcSEcCtD
Escitalopram—Sinus headache—Metformin—metabolic syndrome X	0.00515	0.0375	CcSEcCtD
Escitalopram—Tooth abscess—Metformin—metabolic syndrome X	0.00402	0.0292	CcSEcCtD
Escitalopram—Emotional distress—Metformin—metabolic syndrome X	0.00395	0.0287	CcSEcCtD
Escitalopram—Abdominal bloating—Metformin—metabolic syndrome X	0.00352	0.0256	CcSEcCtD
Escitalopram—Sinus congestion—Metformin—metabolic syndrome X	0.00337	0.0245	CcSEcCtD
Escitalopram—Epigastric discomfort—Metformin—metabolic syndrome X	0.00319	0.0232	CcSEcCtD
Escitalopram—Toothache—Metformin—metabolic syndrome X	0.00276	0.0201	CcSEcCtD
Escitalopram—Upset stomach—Metformin—metabolic syndrome X	0.00256	0.0186	CcSEcCtD
Escitalopram—Heartburn—Metformin—metabolic syndrome X	0.00244	0.0177	CcSEcCtD
Escitalopram—Fungal infection—Metformin—metabolic syndrome X	0.00217	0.0158	CcSEcCtD
Escitalopram—Rhinorrhoea—Metformin—metabolic syndrome X	0.00207	0.0151	CcSEcCtD
Escitalopram—Rigors—Metformin—metabolic syndrome X	0.00205	0.015	CcSEcCtD
Escitalopram—Contusion—Metformin—metabolic syndrome X	0.00192	0.014	CcSEcCtD
Escitalopram—Chest discomfort—Metformin—metabolic syndrome X	0.0019	0.0138	CcSEcCtD
Escitalopram—Accidental injury—Metformin—metabolic syndrome X	0.0019	0.0138	CcSEcCtD
Escitalopram—Neuropathy—Metformin—metabolic syndrome X	0.00158	0.0115	CcSEcCtD
Escitalopram—Lightheadedness—Metformin—metabolic syndrome X	0.0015	0.0109	CcSEcCtD
Escitalopram—Ear pain—Metformin—metabolic syndrome X	0.00143	0.0104	CcSEcCtD
Escitalopram—Nasal congestion—Metformin—metabolic syndrome X	0.00134	0.00973	CcSEcCtD
Escitalopram—Injury—Metformin—metabolic syndrome X	0.00132	0.00964	CcSEcCtD
Escitalopram—Hypoglycaemia—Metformin—metabolic syndrome X	0.00125	0.00908	CcSEcCtD
Escitalopram—Lethargy—Metformin—metabolic syndrome X	0.00124	0.00904	CcSEcCtD
Escitalopram—Pain in extremity—Metformin—metabolic syndrome X	0.00122	0.00886	CcSEcCtD
Escitalopram—Migraine—Metformin—metabolic syndrome X	0.0012	0.00872	CcSEcCtD
Escitalopram—Dehydration—Metformin—metabolic syndrome X	0.00113	0.00824	CcSEcCtD
Escitalopram—Liver function test abnormal—Metformin—metabolic syndrome X	0.00112	0.00818	CcSEcCtD
Escitalopram—Abdominal pain upper—Metformin—metabolic syndrome X	0.00111	0.00809	CcSEcCtD
Escitalopram—Breast disorder—Metformin—metabolic syndrome X	0.0011	0.00801	CcSEcCtD
Escitalopram—Cramp muscle—Metformin—metabolic syndrome X	0.0011	0.00798	CcSEcCtD
Escitalopram—Nasopharyngitis—Metformin—metabolic syndrome X	0.00109	0.00792	CcSEcCtD
Escitalopram—Abdominal distension—Metformin—metabolic syndrome X	0.00106	0.00771	CcSEcCtD
Escitalopram—Influenza—Metformin—metabolic syndrome X	0.00105	0.00766	CcSEcCtD
Escitalopram—Pancreatitis—Metformin—metabolic syndrome X	0.00103	0.00751	CcSEcCtD
Escitalopram—Angina pectoris—Metformin—metabolic syndrome X	0.00103	0.00746	CcSEcCtD
Escitalopram—Sweating increased—Metformin—metabolic syndrome X	0.00103	0.00746	CcSEcCtD
Escitalopram—Abdominal discomfort—Metformin—metabolic syndrome X	0.00101	0.00734	CcSEcCtD
Escitalopram—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000978	0.00712	CcSEcCtD
Escitalopram—Infestation NOS—Metformin—metabolic syndrome X	0.000938	0.00683	CcSEcCtD
Escitalopram—Infestation—Metformin—metabolic syndrome X	0.000938	0.00683	CcSEcCtD
Escitalopram—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00092	0.00669	CcSEcCtD
Escitalopram—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000888	0.00646	CcSEcCtD
Escitalopram—Bradycardia—Metformin—metabolic syndrome X	0.000858	0.00624	CcSEcCtD
Escitalopram—Rhinitis—Metformin—metabolic syndrome X	0.000845	0.00615	CcSEcCtD
Escitalopram—Hepatitis—Metformin—metabolic syndrome X	0.000842	0.00613	CcSEcCtD
Escitalopram—Hypoaesthesia—Metformin—metabolic syndrome X	0.000838	0.0061	CcSEcCtD
Escitalopram—Oedema peripheral—Metformin—metabolic syndrome X	0.00083	0.00604	CcSEcCtD
Escitalopram—Connective tissue disorder—Metformin—metabolic syndrome X	0.000828	0.00602	CcSEcCtD
Escitalopram—Eye disorder—Metformin—metabolic syndrome X	0.000787	0.00573	CcSEcCtD
Escitalopram—Flushing—Metformin—metabolic syndrome X	0.000782	0.00569	CcSEcCtD
Escitalopram—Cardiac disorder—Metformin—metabolic syndrome X	0.000782	0.00569	CcSEcCtD
Escitalopram—Angiopathy—Metformin—metabolic syndrome X	0.000764	0.00556	CcSEcCtD
Escitalopram—Immune system disorder—Metformin—metabolic syndrome X	0.000761	0.00554	CcSEcCtD
Escitalopram—Mediastinal disorder—Metformin—metabolic syndrome X	0.000759	0.00552	CcSEcCtD
Escitalopram—Chills—Metformin—metabolic syndrome X	0.000756	0.0055	CcSEcCtD
Escitalopram—Erythema—Metformin—metabolic syndrome X	0.000733	0.00534	CcSEcCtD
Escitalopram—Malnutrition—Metformin—metabolic syndrome X	0.000733	0.00534	CcSEcCtD
Escitalopram—Flatulence—Metformin—metabolic syndrome X	0.000723	0.00526	CcSEcCtD
Escitalopram—Dysgeusia—Metformin—metabolic syndrome X	0.000718	0.00523	CcSEcCtD
Escitalopram—Muscle spasms—Metformin—metabolic syndrome X	0.000705	0.00513	CcSEcCtD
Escitalopram—Vision blurred—Metformin—metabolic syndrome X	0.000691	0.00503	CcSEcCtD
Escitalopram—Tremor—Metformin—metabolic syndrome X	0.000687	0.005	CcSEcCtD
Escitalopram—Ill-defined disorder—Metformin—metabolic syndrome X	0.00068	0.00495	CcSEcCtD
Escitalopram—Malaise—Metformin—metabolic syndrome X	0.000661	0.00481	CcSEcCtD
Escitalopram—Syncope—Metformin—metabolic syndrome X	0.000658	0.00479	CcSEcCtD
Escitalopram—Palpitations—Metformin—metabolic syndrome X	0.000648	0.00472	CcSEcCtD
Escitalopram—Loss of consciousness—Metformin—metabolic syndrome X	0.000645	0.00469	CcSEcCtD
Escitalopram—Hypertension—Metformin—metabolic syndrome X	0.000633	0.00461	CcSEcCtD
Escitalopram—Myalgia—Metformin—metabolic syndrome X	0.000624	0.00454	CcSEcCtD
Escitalopram—Chest pain—Metformin—metabolic syndrome X	0.000624	0.00454	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00062	0.00451	CcSEcCtD
Escitalopram—Discomfort—Metformin—metabolic syndrome X	0.000617	0.00449	CcSEcCtD
Escitalopram—Oedema—Metformin—metabolic syndrome X	0.000599	0.00436	CcSEcCtD
Escitalopram—Infection—Metformin—metabolic syndrome X	0.000595	0.00433	CcSEcCtD
Escitalopram—Shock—Metformin—metabolic syndrome X	0.000589	0.00428	CcSEcCtD
Escitalopram—Nervous system disorder—Metformin—metabolic syndrome X	0.000587	0.00427	CcSEcCtD
Escitalopram—Thrombocytopenia—Metformin—metabolic syndrome X	0.000586	0.00426	CcSEcCtD
Escitalopram—Skin disorder—Metformin—metabolic syndrome X	0.000581	0.00423	CcSEcCtD
Escitalopram—Hyperhidrosis—Metformin—metabolic syndrome X	0.000579	0.00421	CcSEcCtD
Escitalopram—Anorexia—Metformin—metabolic syndrome X	0.000571	0.00415	CcSEcCtD
Escitalopram—Hypotension—Metformin—metabolic syndrome X	0.000559	0.00407	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000545	0.00397	CcSEcCtD
Escitalopram—Paraesthesia—Metformin—metabolic syndrome X	0.000537	0.00391	CcSEcCtD
Escitalopram—Dyspnoea—Metformin—metabolic syndrome X	0.000534	0.00388	CcSEcCtD
Escitalopram—Somnolence—Metformin—metabolic syndrome X	0.000532	0.00387	CcSEcCtD
Escitalopram—Dyspepsia—Metformin—metabolic syndrome X	0.000527	0.00383	CcSEcCtD
Escitalopram—Decreased appetite—Metformin—metabolic syndrome X	0.00052	0.00379	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000517	0.00376	CcSEcCtD
Escitalopram—Fatigue—Metformin—metabolic syndrome X	0.000516	0.00375	CcSEcCtD
Escitalopram—Constipation—Metformin—metabolic syndrome X	0.000512	0.00372	CcSEcCtD
Escitalopram—Feeling abnormal—Metformin—metabolic syndrome X	0.000493	0.00359	CcSEcCtD
Escitalopram—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000489	0.00356	CcSEcCtD
Escitalopram—Urticaria—Metformin—metabolic syndrome X	0.000476	0.00346	CcSEcCtD
Escitalopram—Abdominal pain—Metformin—metabolic syndrome X	0.000473	0.00344	CcSEcCtD
Escitalopram—Asthenia—Metformin—metabolic syndrome X	0.000429	0.00312	CcSEcCtD
Escitalopram—Pruritus—Metformin—metabolic syndrome X	0.000423	0.00308	CcSEcCtD
Escitalopram—Diarrhoea—Metformin—metabolic syndrome X	0.00041	0.00298	CcSEcCtD
Escitalopram—Dizziness—Metformin—metabolic syndrome X	0.000396	0.00288	CcSEcCtD
Escitalopram—Vomiting—Metformin—metabolic syndrome X	0.000381	0.00277	CcSEcCtD
Escitalopram—Rash—Metformin—metabolic syndrome X	0.000377	0.00275	CcSEcCtD
Escitalopram—Dermatitis—Metformin—metabolic syndrome X	0.000377	0.00274	CcSEcCtD
Escitalopram—Headache—Metformin—metabolic syndrome X	0.000375	0.00273	CcSEcCtD
Escitalopram—Nausea—Metformin—metabolic syndrome X	0.000356	0.00259	CcSEcCtD
Escitalopram—HTR2C—GPCR downstream signaling—AGT—metabolic syndrome X	2.46e-05	0.000524	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TRIB3—metabolic syndrome X	2.46e-05	0.000523	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RBP4—metabolic syndrome X	2.46e-05	0.000523	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TRIB3—metabolic syndrome X	2.45e-05	0.000522	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RBP4—metabolic syndrome X	2.45e-05	0.000522	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	2.45e-05	0.000521	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	2.44e-05	0.000519	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—FABP4—metabolic syndrome X	2.43e-05	0.000518	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.43e-05	0.000517	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TRIB3—metabolic syndrome X	2.41e-05	0.000514	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RBP4—metabolic syndrome X	2.41e-05	0.000514	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	2.4e-05	0.000511	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.36e-05	0.000503	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.32e-05	0.000494	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL5—metabolic syndrome X	2.31e-05	0.000493	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL5—metabolic syndrome X	2.31e-05	0.000491	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.31e-05	0.000491	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HSD11B1—metabolic syndrome X	2.3e-05	0.000491	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.3e-05	0.000489	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL5—metabolic syndrome X	2.27e-05	0.000484	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	2.26e-05	0.000482	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AGT—metabolic syndrome X	2.23e-05	0.000476	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—G6PD—metabolic syndrome X	2.23e-05	0.000475	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—FMO3—metabolic syndrome X	2.23e-05	0.000475	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.2e-05	0.000469	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CYBA—metabolic syndrome X	2.2e-05	0.000468	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HDAC3—metabolic syndrome X	2.18e-05	0.000464	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOC3—metabolic syndrome X	2.18e-05	0.000464	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOC3—metabolic syndrome X	2.17e-05	0.000462	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—GHRL—metabolic syndrome X	2.15e-05	0.000458	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOC3—metabolic syndrome X	2.14e-05	0.000455	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AGT—metabolic syndrome X	2.13e-05	0.000454	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPA—metabolic syndrome X	2.13e-05	0.000454	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GCKR—metabolic syndrome X	2.13e-05	0.000454	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AGT—metabolic syndrome X	2.12e-05	0.000453	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AGT—metabolic syndrome X	2.09e-05	0.000445	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PLA2G6—metabolic syndrome X	2.06e-05	0.000439	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—G6PD—metabolic syndrome X	2.05e-05	0.000437	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.05e-05	0.000436	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOA5—metabolic syndrome X	2.04e-05	0.000435	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CNR1—metabolic syndrome X	2.04e-05	0.000433	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	2e-05	0.000427	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	1.99e-05	0.000423	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	1.99e-05	0.000423	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.98e-05	0.000422	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HTR2C—metabolic syndrome X	1.96e-05	0.000418	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GCKR—metabolic syndrome X	1.96e-05	0.000417	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPA—metabolic syndrome X	1.96e-05	0.000417	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HTR2C—metabolic syndrome X	1.96e-05	0.000417	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.94e-05	0.000414	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AGT—metabolic syndrome X	1.94e-05	0.000412	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AGT—metabolic syndrome X	1.93e-05	0.000411	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HTR2C—metabolic syndrome X	1.93e-05	0.000411	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.92e-05	0.000409	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CYBA—metabolic syndrome X	1.9e-05	0.000405	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AGT—metabolic syndrome X	1.9e-05	0.000405	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TRIB3—metabolic syndrome X	1.9e-05	0.000404	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	1.9e-05	0.000404	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CYBA—metabolic syndrome X	1.9e-05	0.000404	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOA5—metabolic syndrome X	1.88e-05	0.0004	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	1.87e-05	0.000398	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CYBA—metabolic syndrome X	1.87e-05	0.000398	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—GHRL—metabolic syndrome X	1.86e-05	0.000397	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—GHRL—metabolic syndrome X	1.86e-05	0.000395	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCL2—metabolic syndrome X	1.84e-05	0.000392	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—GHRL—metabolic syndrome X	1.83e-05	0.000389	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CNR1—metabolic syndrome X	1.76e-05	0.000376	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CNR1—metabolic syndrome X	1.76e-05	0.000374	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	1.75e-05	0.000372	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CNR1—metabolic syndrome X	1.73e-05	0.000369	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NAMPT—metabolic syndrome X	1.7e-05	0.000363	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.69e-05	0.000361	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GCK—metabolic syndrome X	1.69e-05	0.00036	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LIPC—metabolic syndrome X	1.69e-05	0.00036	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOC3—metabolic syndrome X	1.68e-05	0.000358	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF2—metabolic syndrome X	1.66e-05	0.000354	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CETP—metabolic syndrome X	1.63e-05	0.000348	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOB—metabolic syndrome X	1.62e-05	0.000344	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL2—metabolic syndrome X	1.59e-05	0.00034	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL2—metabolic syndrome X	1.59e-05	0.000338	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—FABP4—metabolic syndrome X	1.59e-05	0.000338	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL5—metabolic syndrome X	1.58e-05	0.000336	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.57e-05	0.000335	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	1.57e-05	0.000334	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL2—metabolic syndrome X	1.56e-05	0.000333	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SCARB1—metabolic syndrome X	1.56e-05	0.000333	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LIPC—metabolic syndrome X	1.56e-05	0.000331	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GCK—metabolic syndrome X	1.56e-05	0.000331	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOC3—metabolic syndrome X	1.55e-05	0.000329	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LPL—metabolic syndrome X	1.54e-05	0.000329	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.52e-05	0.000324	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SREBF1—metabolic syndrome X	1.52e-05	0.000323	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	1.51e-05	0.000321	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CETP—metabolic syndrome X	1.5e-05	0.00032	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GOT2—metabolic syndrome X	1.48e-05	0.000314	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMGCR—metabolic syndrome X	1.48e-05	0.000314	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF2—metabolic syndrome X	1.44e-05	0.000307	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	1.44e-05	0.000306	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF2—metabolic syndrome X	1.44e-05	0.000306	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	1.42e-05	0.000301	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOB—metabolic syndrome X	1.4e-05	0.000298	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	1.4e-05	0.000297	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOB—metabolic syndrome X	1.4e-05	0.000297	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	1.37e-05	0.000293	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL5—metabolic syndrome X	1.37e-05	0.000291	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL5—metabolic syndrome X	1.36e-05	0.00029	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.36e-05	0.00029	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.36e-05	0.000289	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.36e-05	0.000289	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.36e-05	0.000289	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—G6PD—metabolic syndrome X	1.34e-05	0.000286	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	1.34e-05	0.000286	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LPL—metabolic syndrome X	1.34e-05	0.000285	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.34e-05	0.000285	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LPL—metabolic syndrome X	1.33e-05	0.000284	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.33e-05	0.000284	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AGT—metabolic syndrome X	1.32e-05	0.000281	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ABCA1—metabolic syndrome X	1.32e-05	0.00028	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SLC2A4—metabolic syndrome X	1.32e-05	0.00028	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	1.31e-05	0.000279	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	1.31e-05	0.000279	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—LEP—metabolic syndrome X	1.29e-05	0.000275	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOE—metabolic syndrome X	1.29e-05	0.000275	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.28e-05	0.000273	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.28e-05	0.000273	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOA1—metabolic syndrome X	1.28e-05	0.000272	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GOT1—metabolic syndrome X	1.27e-05	0.000271	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GGT1—metabolic syndrome X	1.27e-05	0.000271	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.24e-05	0.000264	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.23e-05	0.000262	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.21e-05	0.000258	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.21e-05	0.000258	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.17e-05	0.00025	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.17e-05	0.00025	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.15e-05	0.000246	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AGT—metabolic syndrome X	1.14e-05	0.000244	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.14e-05	0.000243	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AGT—metabolic syndrome X	1.14e-05	0.000243	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.12e-05	0.000239	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—LEP—metabolic syndrome X	1.12e-05	0.000239	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOE—metabolic syndrome X	1.12e-05	0.000239	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—LEP—metabolic syndrome X	1.12e-05	0.000238	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOE—metabolic syndrome X	1.12e-05	0.000238	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.11e-05	0.000236	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.1e-05	0.000235	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOA1—metabolic syndrome X	1.1e-05	0.000235	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.1e-05	0.000234	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.1e-05	0.000234	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.09e-05	0.000231	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.09e-05	0.000231	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOB—metabolic syndrome X	1.08e-05	0.00023	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.07e-05	0.000228	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	1.05e-05	0.000224	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—LPL—metabolic syndrome X	1.03e-05	0.00022	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.02e-05	0.000218	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.02e-05	0.000217	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.02e-05	0.000217	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.01e-05	0.000216	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.01e-05	0.000215	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1e-05	0.000213	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	9.96e-06	0.000212	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOB—metabolic syndrome X	9.95e-06	0.000212	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CETP—metabolic syndrome X	9.82e-06	0.000209	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CD36—metabolic syndrome X	9.81e-06	0.000209	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	9.81e-06	0.000209	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	9.69e-06	0.000206	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	9.68e-06	0.000206	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—INS—metabolic syndrome X	9.57e-06	0.000204	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—INS—metabolic syndrome X	9.54e-06	0.000203	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—LPL—metabolic syndrome X	9.5e-06	0.000202	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	9.42e-06	0.000201	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	9.4e-06	0.0002	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	9.39e-06	0.0002	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	9.39e-06	0.0002	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	9.26e-06	0.000197	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	9.24e-06	0.000197	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	9.23e-06	0.000197	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	9.13e-06	0.000194	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARA—metabolic syndrome X	9.12e-06	0.000194	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	9.08e-06	0.000193	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CD36—metabolic syndrome X	9.02e-06	0.000192	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	8.88e-06	0.000189	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT2—metabolic syndrome X	8.88e-06	0.000189	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AGT—metabolic syndrome X	8.83e-06	0.000188	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.79e-06	0.000187	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.76e-06	0.000187	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOE—metabolic syndrome X	8.66e-06	0.000184	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.63e-06	0.000184	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOA1—metabolic syndrome X	8.56e-06	0.000182	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	8.39e-06	0.000179	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARA—metabolic syndrome X	8.39e-06	0.000179	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	8.37e-06	0.000178	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8.3e-06	0.000177	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	8.24e-06	0.000175	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	8.17e-06	0.000174	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AGT—metabolic syndrome X	8.12e-06	0.000173	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOE—metabolic syndrome X	7.96e-06	0.00017	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	7.91e-06	0.000169	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	7.91e-06	0.000169	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOA1—metabolic syndrome X	7.87e-06	0.000168	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GOT1—metabolic syndrome X	7.66e-06	0.000163	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GGT1—metabolic syndrome X	7.66e-06	0.000163	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARG—metabolic syndrome X	7.54e-06	0.000161	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.54e-06	0.000161	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—INS—metabolic syndrome X	7.39e-06	0.000157	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.19e-06	0.000153	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.17e-06	0.000153	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	7.08e-06	0.000151	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.06e-06	0.00015	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	7.06e-06	0.00015	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	6.95e-06	0.000148	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARG—metabolic syndrome X	6.93e-06	0.000148	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—INS—metabolic syndrome X	6.8e-06	0.000145	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—metabolic syndrome X	6.78e-06	0.000144	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	6.53e-06	0.000139	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	6.51e-06	0.000139	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOB—metabolic syndrome X	6.5e-06	0.000138	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—metabolic syndrome X	6.48e-06	0.000138	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.41e-06	0.000136	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.41e-06	0.000136	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	6.33e-06	0.000135	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—metabolic syndrome X	6.23e-06	0.000133	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—LPL—metabolic syndrome X	6.21e-06	0.000132	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.96e-06	0.000127	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	5.93e-06	0.000126	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CD36—metabolic syndrome X	5.9e-06	0.000126	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	5.55e-06	0.000118	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	5.53e-06	0.000118	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.48e-06	0.000117	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	5.45e-06	0.000116	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.45e-06	0.000116	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AGT—metabolic syndrome X	5.31e-06	0.000113	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.2e-06	0.000111	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.15e-06	0.00011	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.83e-06	0.000103	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.53e-06	9.65e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.45e-06	9.48e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—INS—metabolic syndrome X	4.45e-06	9.47e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.18e-06	8.91e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	4.17e-06	8.88e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.1e-06	8.74e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.08e-06	8.68e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.9e-06	8.3e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	3.86e-06	8.22e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	3.85e-06	8.19e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.79e-06	8.06e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.57e-06	7.6e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKT1—metabolic syndrome X	2.98e-06	6.35e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.74e-06	5.84e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.79e-06	3.82e-05	CbGpPWpGaD
